VANI Vivani Medical Inc.
Company Analysis
Latest News
🟢 VANI is trading 7.8% up today on Novo Nordisk deal to evaluate semaglutide implant
VANI is trading 7.8% up at $1.46 after announcing an agreement with Novo Nordisk to evaluate NPM-139, a semaglutide implant for chronic weight management. •...
🟢 VANI surges 5.4% today on Novo Nordisk agreement to evaluate semaglutide implant
• Vivani Medical (VANI) announced an agreement with Novo Nordisk to evaluate NPM-139, its semaglutide implant for chronic weight management. • This...
Vivani to Merge Subsidiary Cortigent into ClearOne for 12.5M Shares
Vivani Medical announced a definitive merger agreement for its wholly-owned subsidiary, Cortigent, Inc., to merge with a subsidiary of ClearOne, Inc. In a...
🟢 VANI makes sharp 13.1% jump
VANI is trading at $1.47, up 13.1% versus the comparison close of $1.30 during pre-market. This is a price-movement alert; no separate company-specific...
🟢 VANI surges 9.2% as Vivani Medical announces agreement with Novo Nordisk to evaluate semaglutide implant
Vivani Medical (VANI) is trading 9.2% up at $1.42 in pre-market following news of a significant agreement. The company announced on July 7, 2026, that it has...